Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: A systematic review and meta-analysis of qualitative and quantitative studies

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Khatib, Rasha ^a   Schwalm, Jon David ^a,b   Yusuf, Salim ^a,b   Haynes, R Brian ^b   McKee, Martin ^c   Khan, Maheer ^a   Nieuwlaat, Robby ^a,b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ATTITUDE TO HEALTH; AWARENESS; DEPRESSION; EMOTIONALITY; FINANCIAL MANAGEMENT; FOLLOW UP; FOOD PREFERENCE; HABIT; HEALTH BELIEF; HEALTH CARE AVAILABILITY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDICATION COMPLIANCE; META ANALYSIS; MOTIVATION; PATIENT; PATIENT ATTITUDE; PROFESSIONAL COMPETENCE; PROFESSIONAL IMAGE; PROFESSIONAL STANDARD; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; REVIEW; SOCIAL ADAPTATION; SOCIAL BEHAVIOR; STRESS; SYSTEMATIC REVIEW; PSYCHOLOGY;

AWARENESS; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION;

EID: 84898039187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084238     Document Type: Review

References (86)

1. World Health Organization (2009) Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization.
2. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, et al. (2013) Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310(9):959-68.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment (Pubitemid 37430158)
4. Nieuwlaat R, Schwalm JD, Khatib R, Yusuf S (2013) Why are we failing to implement effective therapies in cardiovascular disease? Eur Heart J. 34(17):1262-9.
5. Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, et al. (2010) Tailored interventions to overcome identified barriers to change: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. (3).
6. Borzecki AM, Oliveria SA, Berlowitz DR (2005) Barriers to hypertension control. Am Heart J. 149(5):785-94. (Pubitemid 40718872)
7. Davies P, Walker AE, Grimshaw JM (2010) A systematic review of the use of theory in the design of guideline dissemination and implementation strategies and interpretation of the results of rigorous evaluations. Implement Sci. 5:14, 5908-5-14.
8. Michie S, Johnston M, Abraham C, Lawton R, Parker D, et al. (2005) Making psychological theory useful for implementing evidence based practice: A consensus approach. Qual Saf Health Care. 14(1):26-33. (Pubitemid 40222377)
9. Fishbein M (2000) The role of theory in HIV prevention. AIDS Care. (3): 273-8. (Pubitemid 30426747)
10. World Health Organization (2000) The world health report-health systems: Improving performance. Geneva: World Health Organization.
11. Higgins J, PT, Green S, editors (2008) Cochrane handbook for systematic reviews of interventions: Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration and John Wiley & Sons Ltd.
12. Kmet ML, Lee CR, Cook SL (2004) Standard Quality Assessment Criteria For Evaluating Primary Research Papers From A Variety Of Fields. Alberta Heritage Foundation For Medical Research.
13. Swift JA, Tischler V (2010) Qualitative research in nutrition and dietetics: Getting started. J Hum Nutr Diet. (6): 559-66.
14. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. (2006) Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. (11): e438.
15. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence biased medicine-selective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications. BMJ. 326(7400):1171-3. (Pubitemid 36649049)
16. Gregoire JP, Moisan J, Guibert R, Ciampi A, Milot A, et al. (2002) Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol. (7): 728-35.
17. Kobalava Z, Kotovskaia I, Starostina EG, Villeval'de SV, Luk'ianova EA, et al (2007). Problems of a physician-patient interaction and control of arterial hypertension in russia. main results of scientific-practical program ARGUS-2. Kardiologiia. 47(3):38-47.
18. Machado MC, Pires CG, Lobao WM (2012) Perceptions of hypertensive people on risk factors for the disease. Cien Saude Colet. (5): 1357-63.
19. Park S, Kwon J, Kim C, Lee Y, Kim H (2012) Development of nutrition education program for hypertension based on health belief model, applying focus group interview. Korean J Community Nutr. 2(5):623-36.
20. Howes F, Hansen E, Nelson M (2012) Management of hypertension in general practice - a qualitative needs assessment of australian GPs. Aust Fam Physician. 41(5):317-23.
21. Howes F, Hansen E, Williams D, Nelson M (2010) Barriers to diagnosing and managing hypertension - a qualitative study in australian general practice. Aust Fam Physician. 39(7):511-6.
22. Parker WA, Steyn NP, Levitt NS, Lombard CJ (2012) Health promotion services for patients having non-comminicable diseases: Feedback from patients and health care providers in cape town, south africa. BMC Public Health. 4;12:503, 2458-12-503.
23. Hernandez J, Anderson S (2012) Storied experiences of nurse practitioners managing prehypertension in primary care. J Am Acad Nurse Pract. 24(2):89-96.
24. Cranney M, Warren E, Barton S, Gardner K, Walley T (2001) Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract. 418(4):359-63. (Pubitemid 32771637)
25. Kusuma SY (2010) Migrants' perceptions on barriers to treatment seeking for hypertension: A qualitative study from delhi, india. Ethnomed. 44(3):173-176.
26. Kasje WN, Denig P, Haaijer-Ruskamp FM (2002) Specialists' expectations regarding joint treatment guidelines for primary and secondary care. Int J Qual Health Care. 14(6):509-18. (Pubitemid 36054424)
27. Crosson JC, Heisler M, Subramanian U, Swain B, Davis GJ, et al. (2010) Physicians' perceptions of barriers to cardiovascular disease risk factor control among patients with diabetes: Results from the translating research into action for diabetes [TRIAD] study. J Am Board Fam Med. 23(2):171-8.
28. Arrieta MI, Foreman RD, Crook ED, Icenogle ML (2009) Providing continuity of care for chronic diseases in the aftermath of katrina: From field experience to policy recommendations. Disaster Med Public Health Prep. 3(3):174-82.
29. Pham TM, Rosenthal MP, Diamond JJ (1999) Hypertension, cardiovascular disease, and health care dilemmas in the philadelphia vietnamese community. Fam Med. 31(9):647-51. (Pubitemid 29482312)
30. Barnes DM, Lu JH (2012) Mexican immigrants' and mexican americans' perceptions of hypertension. Qual Health Res. 22(12):1685-93.
31. Horowitz CR, Tuzzio L, Rojas M, Monteith SA, Sisk JE (2004) How do urban african americans and latinos view the influence of diet on hypertension? J Health Care Poor Underserved. 15(4):631-44. (Pubitemid 39531409)
32. Wexler R, Elton T, Taylor CA, Pleister A, Feldman D (2009) Physician reported perception in the treatment of high blood pressure does not correspond to practice. BMC Fam Pract. 10:23, 2296-10-23.
33. Peters DH, Garg A, Bloom G, Walker DG, Brieger WR, et al. (2008) Poverty and access to health care in developing countries. Ann N Y Acad Sci. 1136:161-71. (Pubitemid 351862164)
34. Anthony H, Valinsky L, Inbar Z, Gabriel C, Varda S (2012) Perceptions of hypertension treatment among patients with and without diabetes. BMC Fam Pract. 13:24, 2296-13-24.
35. Murimi MW, Harpel T (2010) Practicing preventive health: The underlying culture among low-income rural populations. J Rural Health. 26(3):273-82.
36. Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP (2004). Barriers and facilitators of medication adherence in hypertensive african americans: A qualitative study. Ethn Dis. 14(1):3-12. (Pubitemid 38262740)
37. Ford CD, Kim MJ, Dancy BL (2009) Perceptions of hypertension and contributing personal and environmental factors among rural southern african american women. Ethn Dis. 19(4):407-13.
38. Schafheutle EI, Hassell K, Noyce PR, Weiss MC (2002) Access to medicines: Cost as an influence on the views and behaviour of patients. Health Soc Care Community. 10(3):187-95. (Pubitemid 36844273)
39. Fongwa MN, Evangelista LS, Hays RD, Martins DS, Elashoff D, et al. (2008) Adherence treatment factors in hypertensive african american women. Vasc Health Risk Manag. 4(1):157-66. (Pubitemid 351460856)
40. Aroian KJ, Peters RM, Rudner N, Waser L (2012) Hypertension prevention beliefs of hispanics. J Transcult Nurs. 23(2):134-42.
41. Wexler R, Elton T, Pleister A, Feldman D (2009) Barriers to blood pressure control as reported by african american patients. J Natl Med Assoc. 101(6):597-603.
42. Greer TM (2010) Perceived racial discrimination in clinical encounters among african american hypertensive patients. J Health Care Poor Underserved. 21(1):251-63.
43. Dean SC, Kerry SM, Cappuccio FP, Oakeshott P (2007) Pilot study of potential barriers to blood pressure control in patients with inadequately controlled hypertension. Fam Pract. 24(3):259-62. (Pubitemid 47249458)
44. Coleman MT, Lott JA, Sharma S (2000) Use of continuous quality improvement to identify barriers in the management of hypertension. Am J Med Qual. 15(2):72-7.
45. Mendis S, Abegunde D, Oladapo O, Celletti F, Nordet P (2004) Barriers to management of cardiovascular risk in a low-resource setting using hypertension as an entry point. J Hypertens. 22(1):59-64. (Pubitemid 38293531)
46. Cornuz J, Ghali WA, Di Carlantonio D, Pecoud A, Paccaud F (2000) Physicians' attitudes towards prevention: Importance of intervention-specific barriers and physicians' health habits. Fam Pract. 17(6):535-40. (Pubitemid 32040838)
47. Holland N, Segraves D, Nnadi VO, Belletti DA, Wogen J, et al. (2008) Identifying barriers to hypertension care: Implications for quality improvement initiatives. Dis Manag. 11(2):71-7. (Pubitemid 351571047)
48. Mahabir D, Gulliford MC (1997) Medical practitioners' views on the management of hypertension in trinidad and tobago. West Indian Med J. 46(3):88-91. (Pubitemid 27473290)
49. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, et al. (2002) Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med; 162(4):413-20. (Pubitemid 34150642)
50. Reiner Z, Sonicki Z, Tedeschi-Reiner E (2010) Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey. Atherosclerosis. 213(2):598-603.
51. Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, et al. (2007) Clinical inertia: A common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf.; 33(5):277-85.
52. Wang L (2004) Physician-related barriers to hypertension management. Med Princ Pract. Sep-Oct; 13(5):282-5. (Pubitemid 39179143)
53. Lin ND, Martins SB, Chan AS, Coleman RW, Bosworth HB, et al. (2006) Identifying barriers to hypertension guideline adherence using clinician feedback at the point of care. AMIA Annu Symp Proc.: 494-8.
54. Heneghan C, Perera R, Mant D, Glasziou P (2007) Hypertension guideline recommendations in general practice: Awareness, agreement, adoption, and adherence. Br J Gen Pract. 57(545):948-52.
55. Thorpe JM, Kalinowski CT, Patterson ME, Sleath BL (2006) Psychological distress as a barrier to preventive care in community-dwelling elderly in the united states. Med Care. 44(2):187-91. (Pubitemid 43755471)
56. Edelman DJ, Gao Q, Mosca L (2008) Predictors and barriers to timely medical follow-up after cardiovascular disease risk factor screening according to race/ethnicity. J Natl Med Assoc. 100(5):534-9. (Pubitemid 351717365)
57. Bovet P, Gervasoni JP, Mkamba M, Balampama M, Lengeler C, et al. (2008) Low utilization of health care services following screening for hypertension in dar es salaam [tanzania]: A prospective population-based study. BMC Public Health.; 8:407, 2458-8-407.
58. Wee LE, Koh GC (2012) Individual and neighborhood social factors of hypertension management in a low-socioeconomic status population: A community-based case-control study in singapore. Hypertens Res.; 35(3):295-303.
59. Youssef RM, Moubarak II (2002) Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J. 8(4-5):579-92. (Pubitemid 39654825)
60. Mochari H, Ferris A, Adigopula S, Henry G, Mosca L (2007) Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Prev Cardiol. 10(4):190-5.
61. Serour M, Alqhenaei H, Al-Saqabi S, Mustafa AR, Ben-Nakhi A (2007) Cultural factors and patients' adherence to lifestyle measures. Br J Gen Pract. 57(537):291-5. (Pubitemid 46534192)
62. Ahluwalia JS, McNagny SE, Rask KJ (1997) Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med. 12(1):7-14. (Pubitemid 27114061)
63. Williams MV, Baker DW, Parker RM, Nurss JR (1998) Relationship of functional health literacy to patients' knowledge of their chronic disease. A study of patients with hypertension and diabetes. Arch Intern Med. 26;158(2):166-72. (Pubitemid 28049510)
64. Dennison CR, Peer N, Steyn K, Levitt NS, Hill MN (2007) Determinants of hypertension care and control among peri-urban black south africans: The HiHi study. Ethn Dis. 17(3):484-91. (Pubitemid 47606756)
65. Joyner-Grantham J, Mount DL, McCorkle OD, Simmons DR, Ferrario CM, et al. (2009) Self-reported influences of hopelessness, health literacy, lifestyle action, and patient inertia on blood pressure control in a hypertensive emergency department population. Am J Med Sci.; 338(5):368-72.
66. Gee ME, Bienek A, Campbell NR, Bancej CM, Robitaille C, et al. (2012) Prevalence of, and barriers to, preventive lifestyle behaviors in hypertension [from a national survey of canadians with hypertension]. Am J Cardiol.; 109(4):570-5.
67. Hassan NB, Hasanah CI, Foong K, Naing L, Awang R, et al. (2006) Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens.; 20(1):23-9.
68. Peltzer K (2004) Health beliefs and prescription medication compliance among diagnosed hypertension clinic attenders in a rural south african hospital. Curationis.; 27(3):15-23.
69. Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C (2009) Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf.; 18(8):672-81.
70. Cummings KM, Kirscht JP, Binder LR, Godley AJ (1982) Determinants of drug treatment maintenance among hypertensive persons in inner city detroit. Public Health Rep.; 97(2):99-106. (Pubitemid 12039643)
71. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS (2009) Barriers to and determinants of medication adherence in hypertension management: Perspective of the cohort study of medication adherence among older adults. Med Clin North Am.; 93(3):753-69.
72. Nelson EC, Stason WB, Neutra RR, Solomon HS, McArdle PJ (1978) Impact of patient perceptions on compliance with treatment for hypertension. Med Care.; 16(11):893-906. (Pubitemid 9071829)
73. Hsu YH, Mao CL, Wey M (2010) Antihypertensive medication adherence among elderly chinese americans. J Transcult Nurs.; 21(4):297-305.
74. Gee ME, Campbell NR, Gwadry-Sridhar F, Nolan RP, Kaczorowski J, et al. (2012) Antihypertensive medication use, adherence, stops, and starts in canadians with hypertension. Can J Cardiol.; 28(3):383-9.
75. Hong TB, Oddone EZ, Dudley TK, Bosworth HB (2006) Medication barriers and anti-hypertensive medication adherence: The moderating role of locus of control. Psychol Health Med.; 11(1):20-8. (Pubitemid 43062338)
76. Thomas D, Binny M, Sekhar S, Kishore G, Sasidharan S (2011) Medication adherence and associated barriers in hypertension management in india. CVD Prevention and Control.; 6:9-13.
77. Hill MN, Bone LR, Kim MT, Miller DJ, Dennison CR, et al. (1999) Barriers to hypertension care and control in young urban black men. Am J Hypertens.; 12(10 Pt 1):951-8. (Pubitemid 29528693)
78. Shulman NB, Martinez B, Brogan D, Carr AA, Miles CG (1986) Financial cost as an obstacle to hypertension therapy. Am J Public Health.; 76(9):1105-8. (Pubitemid 16012419)
79. Oliveria SA, Chen RS, McCarthy BD, Davis CC, Hill MN (2005) Hypertension knowledge, awareness, and attitudes in a hypertensive population. J Gen Intern Med.; 20(3):219-25. (Pubitemid 40628724)
80. Machado MC, Pires CG, Lobao WM (2012) Perceptions of hypertensive people on risk factors for the disease. Cien Saude Colet.; 17(5):1357-63.
81. Wee LE, Koh GC (2012) Individual and neighborhood social factors of hypertension management in a low-socioeconomic status population: A community-based case-control study in singapore. Hypertens Res.; 35(3):295-303.
82. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T (2010) Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 17; (3).
83. Dusing R (2006) Overcoming barriers to effective blood pressure control in patients with hypertension. Curr Med Res Opin.; 22(8):1545-53. (Pubitemid 44297433)
84. Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE (2012) Knowledge translation of research findings. Implement Sci.; 7:50, 5908-7-50.
85. Van Achterberg T, Huisman-De Waal GG, Ketelaar NA, Oostendorp RA, Jacobs JE, et al. (2011) How to promote healthy behaviours in patients? an overview of evidence for behaviour change techniques. Health Promot Int.; 26(2):148-62.
86. Al Ghurair SA, Hughes CA, Simpson SH, Guirguis LM (2012) A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model. J Clin Hypertens [Greenwich]; 14(12):877-86.